Who
Kevin Esch
Executive Vice President
Company insider
Files Form 4 as: Executive Vice President, Zoetis.
In numbers
- Trades disclosed
- 37
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 9 Jan 2026
- Last trade
- 9 Oct 2026
- Last filed
- 13 Oct 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Oct 2026filed 13 Oct 2026 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $9,423360.073 at $26.17 | filing |
| 10 Jul 2026filed 14 Jul 2026 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $8,077308.046 at $26.22 | filing |
| 10 Jul 2026filed 14 Jul 2026 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $8,077308.05 at $26.22 | filing |
| 30 Apr 2026filed 1 May 2026 | ZTS ZoetisPharmaceuticals | SEC FORM 4 Code M | —259 | filing |
| 30 Apr 2026filed 1 May 2026 | ZTS ZoetisPharmaceuticals | SEC FORM 4 Code F | $8,62375 at $114.97 | filing |
| 30 Apr 2026filed 1 May 2026 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —259.922 | filing |
| 30 Apr 2026filed 1 May 2026 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —259.92 | filing |
| 30 Apr 2026filed 1 May 2026 | ZTS ZoetisPharmaceuticals | SEC FORM 4 Code M | —259 | filing |
| 30 Apr 2026filed 1 May 2026 | ZTS ZoetisPharmaceuticals | SEC FORM 4 Code F | $8,62375 at $114.97 | filing |
| 10 Apr 2026filed 13 Apr 2026 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $551.395 at $39.64 | filing |
| 10 Apr 2026filed 13 Apr 2026 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $551.39 at $39.64 | filing |
| 27 Mar 2026filed 31 Mar 2026 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $8,402219.953 at $38.20 | filing |
| 27 Mar 2026filed 31 Mar 2026 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $8,402219.95 at $38.20 | filing |
| 19 Feb 2026filed 23 Feb 2026 | ZTS ZoetisPharmaceuticals | SEC FORM 4 Code M | —102 | filing |
| 19 Feb 2026filed 23 Feb 2026 | ZTS ZoetisPharmaceuticals | SEC FORM 4 Code F | $4,45535 at $127.28 | filing |
| 19 Feb 2026filed 23 Feb 2026 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —102.43 | filing |
| 19 Feb 2026filed 23 Feb 2026 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —102.43 | filing |
| 19 Feb 2026filed 23 Feb 2026 | ZTS ZoetisPharmaceuticals | SEC FORM 4 Code M | —102 | filing |
| 19 Feb 2026filed 23 Feb 2026 | ZTS ZoetisPharmaceuticals | SEC FORM 4 Code F | $4,45535 at $127.28 | filing |
| 18 Feb 2026filed 19 Feb 2026 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —4,026 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.